Sonder Ventures

sondercapital.com

VCMatch tracks Sonder Ventures as an investor focused on Medtech, Digital Health, and Robotics companies and Pre-Seed and Seed rounds. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B

Focus Areas

Medtech, Digital Health, Robotics

Geography

Not specified

Investment Thesis

Sonder Capital’s investment philosophy is to back early-stage, transformational healthcare technologies and teams that can “create a new standard of care.” They position themselves as “Foundational Investors,” committing both capital and hands-on operational support from company inception through acquisition or IPO, leveraging decades of medtech operating experience to help entrepreneurs navigate critical early decisions.

Is Sonder Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Sonder Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Medtech, Digital Health, Robotics, and Hardware.

Focus statement

Sonder focuses on medical device, diagnostic and healthtech companies with transformational technologies and business models and with the opportunity for a $1B+ market cap; they invest early and act as active, strategic partners.

Value Add

Foundational Investor model — "we commit our energy and capital early to guide and support companies from inception to acquisition or IPO."
Active, operational engagement — "partnering with our entrepreneurs as strategic advisors and providing more than just capital."
Deep medtech operating experience — team members are former founders, executives, and board members who have "overcome many of the hurdles faced by entrepreneurs."
Explicit diversity access point — while generally taking inbound pitches from a referral network, they state that "if you as a CEO or Founder are a minority, a woman or another underrepresented individual in the industry, we accept direct requests without a referral."
Clear exit-scale target — portfolio focus is on companies "with the opportunity for a $1B+ market cap."
Advisor network of industry pioneers — advisors described as "industry pioneers across venture capital and medtech" providing strategic insights and operating knowledge.